InsidersTradesSigma
Track the 아이진 stock price and the full insider trade history of the company, a listed equity based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 아이진 has published 72 insider filings. Market capitalisation: €82bn. The latest transaction was reported on 22 June 2026 (Purchase). Among the most active insiders: 한국비엠아이. The full history is accessible without an account.
71
Insider Decl.
n/a
Thresholds
n/a
40 ops.
Buy Volume
n/a
2 ops.
Sell Volume
Fundamental score
Ranked 26,614 of 29,156 companies
20.3
score / 100
Value15
Quality26
FCF yld-8.6%
Earn yld-19%
EV/EBITDA·
ROE-44%
Gross mgn31%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 22 June 2026
Declarations72 total
Other
25 of 72 declarations
About 아이진
아이진 is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in the development of innovative pharmaceutical products.